Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 629,000 $ 255,000
Cost of revenue 560,000 338,000
Gross profit (deficit) 69,000 (83,000)
Operating Expenses:    
Research and development 2,361,000 1,715,000
Sales and marketing 1,495,000 929,000
General and administrative 5,644,000 1,431,000
Total operating expenses 9,500,000 4,075,000
Loss from operations (9,431,000) (4,158,000)
Interest expense, net (120,000) (1,265,000)
Change in fair value of warrant liabilities 17,000 8,129,000
Other expense, net (29,000) 1,000
Income (loss) before provision for income taxes (9,563,000) 2,707,000
Provision for income taxes 0 0
Net income (loss) (9,563,000) 2,707,000
Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock   (5,842,000)
Net loss attributable to common stockholders $ (9,563,000) $ (3,135,000)
Net loss per common share- basic (in dollars per share) $ (0.18) $ (5.35)
Net loss per common share- diluted (in dollars per share) $ (0.18) $ (5.35)
Weighted average number of common shares used in computing net loss per common share - Basic (in shares) 53,681,828 585,500
Weighted average number of common shares used in computing net loss per common share - Diluted (in shares) 53,681,828 585,500